Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection

Analytical Biochemistry

Volumn 396, Issue 1, 2010, Pages 51-58

  Gómara, Maria J ^a   Fernández, Leticia ^a   Pérez, Teresa ^a   Ercilla, Guadalupe ^b   Haro, Isabel ^a  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

GB virus C; Immunoassays; Multiple antigen peptide; Peptides; Surface plasmon resonance

Indexed keywords

ANTIBODIES; BIOSYNTHESIS; CHEMICAL DETECTION; EPITOPES; SURFACE PLASMON RESONANCE; VIRUSES;

HEPATITIS C VIRUS; IMMUNOASSAYS; LINEAR PEPTIDES; LINEAR SEQUENCE; MULTIPLE ANTIGEN PEPTIDES; MULTIPLE ANTIGENIC PEPTIDE; NONSTRUCTURAL PROTEINS; SYNTHETIC PEPTIDE;

PEPTIDES;

CHIMERIC MULTIPLE ANTIGENIC PEPTIDE; NONSTRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 5; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; BIOSENSOR; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SERODIAGNOSIS; SURFACE PLASMON RESONANCE;

GB VIRUS C; HEPATITIS C VIRUS;

EID: 70449624819     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.09.011     Document Type: Article

References (44)

1. Mphahlele M.J., Lau G.K., and Carman W.F. HGV: the identification, biology and prevalence of an orphan virus. Liver 18 3 (1998) 143-155
2. Theodore D., and Lemon S.M. GB virus C, hepatitis G virus, or human orphan flavivirus?. Hepatology 25 5 (1997) 1285-1286
3. Baggio-Zappia G.L., and Hernandes Granato C.F. HIV-GB virus C co-infection: an overview. Clin. Chem. Lab. Med. 47 1 (2009) 12-19
4. Di Bisceglie A.M. Hepatitis G virus infection: a work in progress. Ann. Intern. Med. 125 9 (1996) 772-773
5. Feucht H.H., Zollner B., Polywka S., et al. Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J. Clin. Microbiol. 35 3 (1997) 767-768
6. Saitoh H., Moriyama M., Matsumura H., Goto I., Tanaka N., and Aarakawa Y. The clinical significance of GBV-C/HGV exposure in C-viral chronic liver disease and blood donors. Hepatol. Res. 22 4 (2002) 288-296
7. Tanaka E., Alter H.J., Nakatsuji Y., et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann. Intern. Med. 125 9 (1996) 740-743
8. Rambusch E.G., Wedemeyer H., Tillmann H.L., Heringlake S., and Manns M.P. Significance of coinfection with hepatitis G virus for chronic hepatitis C-a review of the literature. Z. Gastroenterol. 36 1 (1998) 41-53
9. Benhamou Y., Bochet M., Di M.V., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30 4 (1999) 1054-1058
10. Berzsenyi M.D., Bowden D.S., Kelly H.A., et al. Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology 133 6 (2007) 1821-1830
11. Hosseini-Moghaddam S.M., Keyvani H., Samadi M., et al. GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus. J. Med. Virol. 80 7 (2008) 1260-1263
12. Kunkel U., Hohne M., Berg T., et al. Quality control study on the performance of GB virus C/hepatitis G virus PCR. J. Hepatol. 28 6 (1998) 978-984
13. Tacke M., Kiyosawa K., Stark K., et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 349 9048 (1997) 318-320
14. Reshetnyak V.I., Karlovich T.I., and Ilchenko L.U. Hepatitis G virus. World J. Gastroenterol. 14 30 (2008) 4725-4734
15. Tacke M., Schmolke S., Schlueter V., et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 26 6 (1997) 1626-1633
16. Thomas D.L., Vlahov D., Alter H.J., et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J. Infect. Dis. 177 3 (1998) 539-542
17. Toniutto P., Fabris C., Barbone F., et al. Immunoreactivity to putative B-cell epitopes of hepatitis G virus polyprotein in viremic and nonviremic subjects. Clin. Diagn. Lab. Immunol. 6 4 (1999) 573-576
18. Berzsenyi M.D., and Roberts S.K. What is the role of GB virus C infection in hepatitis C virus/HIV coinfection?. J. Infect. Dis. 194 4 (2006) 407-409
19. Fernandez-Vidal M., Cubero M.D., Ercilla G., Gomara M.J., and Haro I. Application of a chimeric synthetic peptide in the development of a serologic method for the diagnosis of hepatitis G virus infection. Protein Pept. Lett. 14 9 (2007) 865-870
20. Perez T., Ercilla G., Chan W.C., and Haro I. Antigenicity of chimeric and cyclic synthetic peptides based on nonstructural proteins of GBV-C/HGV. J. Pept. Sci. 12 4 (2006) 267-278
21. Rojo N., Ercilla G., and Haro I. GB virus C (GBV-C)/hepatitis G virus (HGV): towards the design of synthetic peptides-based biosensors for immunodiagnosis of GBV-C/HGV infection. Curr. Protein Pept. Sci. 4 4 (2003) 291-298
22. Haro I., Perez S., Garcia M., Chan W.C., and Ercilla G. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. FEBS Lett. 540 1-3 (2003) 133-140
23. Bycroft B.W., Chan W.C., Chhabra S.R., and Hone N.D. A novel lysine-protecting procedure for continuous-flow solid-phase synthesis of branched peptides. J. Chem. Soc. Chem. Commun. 9 (1993) 778-779
24. Tam J.P. Recent advances in multiple antigen peptides. J. Immunol. Methods 196 1 (1996) 17-32
25. Kim P., and Pau C.P. Comparing tandem repeats and multiple antigenic peptides as the antigens to detect antibodies by enzyme immunoassay. J. Immunol. Methods 257 1-2 (2001) 51-54
26. Pau C.P., Luo W., and McDougal J.S. Chimeric multiple antigenic peptides for simultaneous detection of specific antibodies to HIV-1 groups M, N, O, and HIV-2. J. Immunol. Methods 318 1-2 (2007) 59-64
27. Gomara M.J., Riedemann S., Vega I., Ibarra H., Ercilla G., and Haro I. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. J. Immunol. Methods 234 1-2 (2000) 23-34
28. Gruber P., Suhr M., Frey A., Becker W.M., and Hofmann T. Development of an epitope-specific analytical tool for the major peanut allergen Ara h 2 using a high-density multiple-antigenic peptide strategy. Mol. Nutr. Food Res. 48 6 (2004) 449-458
29. Oladepo D.K., Klapper P.E., and Marsden H.S. Peptide based enzyme-linked immunoassays for detection of anti-HSV-2 IgG in human sera. J. Virol. Methods 87 1-2 (2000) 63-70
30. Lam L.L., Pau C.P., Dollard S.C., Pellett P.E., and Spira T.J. Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1. J. Clin. Microbiol. 40 2 (2002) 325-329
31. Ghirardello A., Caponi L., Franceschini F., et al. Diagnostic tests for antiribosomal p protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J. Autoimmun. 19 1-2 (2002) 71-77
32. In: Chan W.C., White P.D., Chan W.C., and White P.D. (Eds). Fmoc Solid Phase Peptide Synthesis: A Practical Approach (2000), Oxford University Press, Oxford
33. Barrera J.M., Francis B., Ercilla G., et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang. 68 1 (1995) 15-18
34. Cavazza S., and Lagging M. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors. Scand. J. Infect. Dis. 37 6-7 (2005) 488-492
35. Maylin S., Martinot-Peignoux M., Ripault M.P., et al. Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody. Liver Int. 29 4 (2009) 511-517
36. Vaisocherova H., Faca V.M., Taylor A.D., Hanash S., and Jiang S. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera. Biosens. Bioelectron. 24 7 (2009) 2143-2148
37. Homola J. Surface plasmon resonance sensors for detection of chemical and biological species. Chem. Rev. 108 2 (2008) 462-493
38. Gomara M.J., Ercilla G., Alsina M.A., and Haro I. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology. J. Immunol. Methods 246 1-2 (2000) 13-24
39. Wittekindt C., Fleckenstein B., Wiesmuller K., Eing B.R., and Kuhn J.E. Detection of human serum antibodies against type-specifically reactive peptides from the N-terminus of glycoprotein B of herpes simplex virus type 1 and type 2 by surface plasmon resonance. J. Virol. Methods 87 1-2 (2000) 133-144
40. Wilson K.M., Di Camillo C., Doughty L., and Dax E.M. Humoral immune response to primary rubella virus infection. Clin. Vaccine Immunol. 13 3 (2006) 380-386
41. Vaisocherova H., Mrkvova K., Piliarik M., Jinoch P., Steinbachova M., and Homola J. Surface plasmon resonance biosensor for direct detection of antibody against Epstein-Barr virus. Biosens. Bioelectron. 22 6 (2007) 1020-1026
42. Ayela C., Roquet F., Valera L., Granier C., Nicu L., and Pugniere M. Antibody-antigenic peptide interactions monitored by SPR and QCM-D. A model for SPR detection of IA-2 autoantibodies in human serum. Biosens. Bioelectron. 22 12 (2007) 3113-3119
43. Campagnolo C., Meyers K.J., Ryan T., et al. Real-time, label-free monitoring of tumor antigen and serum antibody interactions. J. Biochem. Biophys. Methods 61 3 (2004) 283-298
44. Cao C., Kim J.P., Kim B.W., et al. A strategy for sensitivity and specificity enhancements in prostate specific antigen-alpha1-antichymotrypsin detection based on surface plasmon resonance. Biosens. Bioelectron. 21 11 (2006) 2106-2113